Trump said he doesn't see a recession after the bond market spooked investors and the Dow suffered its worst day of the year last week.Marketsread more
The U.K. prime minister prepares to meet his German and French counterparts this week.Europe Politicsread more
Amazon is raising seller fees for thousands of small and medium-sized businesses in France because of a new digital tax passed by the French government.Technologyread more
Ahead of the deadline, U.S. President Donald Trump told reporters that Huawei was a national security threat.Technologyread more
Baidu is gearing up to release its second-quarter earnings on Monday with the market expecting a sharp decline in profit.Technologyread more
Americans now say they approve of free trade by 64%-27%, a margin of better than two to one. That's up from 57%-37% early in Trump's presidency, and 51%-41% near the end of...Politicsread more
Stocks in Asia rose on Monday as U.S. Treasury yields bounced higher after plunging last week.Asia Marketsread more
The problem with tanking equities lies elsewhere, writes Michael Ivanovitch, because traders see no end to America's unfolding trade disputes with Europe and China.World Economyread more
Beijing wants to use reforms to support a slowing economy.China Marketsread more
Trump said Cook made a "good case" that it would be difficult for Apple to pay tariffs, when Samsung does not face the same hurdle because much of its manufacturing is in...Technologyread more
The yield on the benchmark 10-year Treasury note briefly fell below the 2-year rate on Wednesday, a phenomenon in the bond market known as yield curve inversion, which is...Marketsread more
Sometimes Jim Cramer tells a caller that he needs to do homework before he can make a decision on a stock. And he's not kidding.
Following is Cramer's research or homework on stocks recently called to his attention by investors who watch the TV show.
On September 17th, Ken in New Jersey asked about Nektar Therapeutics.
"Shares fell 21% on Friday after Nektar announced that an important clinical trial of their drug for chronic pain missed its primary endpoint," Cramer said.
Is the setback a reason to run or should you buy the dip?
"Wait for the dust to settle," Cramer said. "This is a serious blow, but the company still has the rights to five drug candidates in phase 3 trials, and they're having an R&D day on October 8th. See what comes out of the meeting, then make a decision."
GT Advanced Technologies
On September 26th John in Nevada called about GT Advanced Technologies.
Cramer did some digging and found that the stock advanced about 30% in less than a month due to reports that the new iPhone and Samsung's smart watch had incorporated some of GT's technology.
"While these are both positives, they're not home-run opportunities," Cramer said. Given the recent move, I think you need to wait for a pullback in GTAT before you even consider buying it."
And Cramer sees other reasons to like this stock.
Read More from Mad Money with Jim Cramer
Cramer: 10 stocks big money is buying
Domestic stock beyond DC's reach
Massive fine bargain for investors: Cramer
On Friday September 13th, Bob in New York asked about .
"Since May, it's rallied 338%," Cramer said. "Yet even up here, I think Insys trades at a reasonable valuation, and it also looks to me like a viable takeover target. If you already own Insys, I suggest ringing the register on some of your position after this magnificent run, but then let the rest ride because the opportunity here is far from over."
"In fact, I intend to do a further deep dive on this one if heat from Washington melts the market. Yep, I like it that much," added Cramer.
On Monday September 16th Ray in Michigan asked about .
"Cyan is a recent, and fairly disappointing, telecom equipment IPO," Cramer said. "It looks like investors were disappointed with the guidance and the product mix from its first quarterly report as a public company. The first report out of the gate is always important, and when a newly-minted IPO blows it, the stock is going to have to spend some time in the penalty box. We need to see a good quarter here before I'd be willing to circle back."
Call Cramer: 1-800-743-CNBC
Questions for Cramer? firstname.lastname@example.org
Questions, comments, suggestions for the "Mad Money" website? email@example.com